RightFit
RecruitingNot applicable

Testing a Mammography Decision Intervention in a Rural Setting

Toward Optimization of a Mammography Decision Aid and Clinician Communication Intervention Trial for Rural Settings

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
39 Years to 49 Years
Sex
Female only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Questionnaires, Interviews

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Participants will receive acceptability surveys and investigators will conduct qualitative interviews with patients and PCPs to understand experiences with trial implementation from multiple perspectives."
  • "Data Collection: Surveys will be conducted at baseline (pre-intervention), post-DA and Post-Visit."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This pilot study tests MyMammogram, a tool to help women make choices about mammograms (breast X-rays), in rural primary care clinics. It compares the tool alone, the tool with a risk summary sent to the provider before the visit, and usual care. It is for women ages 39–49 and primary care providers at participating clinics.

The overall objective of this COBRE pilot project is to enhance the design of a 3-arm cluster randomized trial that will test the efficacy and mechanism of effect of the MyMammogram DA with or without a provider communication intervention. This will be accomplished through two aims: (1) Refine, with community partner input, a clinical trial protocol to optimize engagement among patients and primary care providers (PCPs) practicing in rural settings. In consultation with patients, PCPs, and informatics experts, the study team will refine site selection, randomization, patient and PCP recruitment, and data collection protocols to meet the needs of the rural health care delivery system and participants. The result of this aim will be a modified protocol and intervention strategy that is acceptable to partners. (2) Adapt and test trial and intervention implementation features to achieve protocol acceptance and adherence. The investigators will pilot the adapted three-arm randomized trial protocol in rural primary care settings that compares the MyMammogram DA with or without a risk summary provided to the PCP pre-visit, relative to usual care. Implementing the trial in two phases (n=15 each) will systematically identify barriers and facilitators to trial participation to refine protocols. Participants will receive acceptability surveys and investigators will conduct qualitative interviews with patients and PCPs to understand experiences with trial implementation from multiple perspectives.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Patients: Female and age 39–49.
  • Patients: Have a visit with a participating primary care provider within 4 weeks.
  • Patients: Speak English or Spanish.
  • Clinicians: Work as a primary care provider at a participating clinic.

Who can't join

  • Patients: Have a history of breast cancer or certain abnormal breast cell changes, including lobular carcinoma in situ, ductal carcinoma in situ, or atypical hyperplasia.
  • Patients: Had a mammogram in the past 9 months.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Patient Inclusion Criteria: * Females * Aged 39-49 * Upcoming appointment with a participating primary care provider (within 4 weeks) * English or Spanish-speaking Patient Exclusion Criteria: * Personal history of breast cancer (including lobular carcinoma in situ and ductal carcinoma in situ or atypical hyperplasia) * Mammogram in the prior 9 months Clinician inclusion: Any practicing primary care provider at a participating site.

Study sites (3)

NH